ConductScience.org, home

Paper36959802

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer.

Ni R and 6 others. Front Oncol, 2023. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer. Papers, record 36959802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36959802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer.
PubMed
Journal
Front Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
5.2
iCite
Revised in PubMed
2023-03-25
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ni RRui
2Li ZZiwei
3Li LLi
4Peng DDan
5Ming YYue
6Li LLin
7Liu YYao

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References227

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132859034Amino Acid Transporters as Targets for Cancer Therapy: Why, Where, When, and How.Int J Mol Sci2020https://conductscience.org/library/papers/32859034PubMed
221993244RAS oncogenes: weaving a tumorigenic web.Nat Rev Cancer2011https://conductscience.org/library/papers/21993244PubMed
329100325Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo.Oncotarget2017https://conductscience.org/library/papers/29100325PubMed
425947346Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients.J Transl Med2015https://conductscience.org/library/papers/25947346PubMed
532483461Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation.Theranostics2020https://conductscience.org/library/papers/32483461PubMed
626444490Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening.PLoS Comput Biol2015https://conductscience.org/library/papers/26444490PubMed
7329078365-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers.Cancer Res2020https://conductscience.org/library/papers/32907836PubMed
824696726Expression of glutaminase is upregulated in colorectal cancer and of clinical significance.Int J Clin Exp Pathol2014https://conductscience.org/library/papers/24696726PubMed
933320840Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.J Clin Invest2021https://conductscience.org/library/papers/33320840PubMed
1035955600Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma.Int J Mol Sci2022https://conductscience.org/library/papers/35955600PubMed
1110619430Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission.Cell1999https://conductscience.org/library/papers/10619430PubMed
1230293904Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.Eur Urol2019https://conductscience.org/library/papers/30293904PubMed
1324094812Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.Cancer Cell2013https://conductscience.org/library/papers/24094812PubMed
1430258985ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer.Sci Adv2018https://conductscience.org/library/papers/30258985PubMed
1521813650Green tea polyphenols control dysregulated glutamate dehydrogenase in transgenic mice by hijacking the ADP activation site.J Biol Chem2011https://conductscience.org/library/papers/21813650PubMed
1629156762Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation.Oncotarget2017https://conductscience.org/library/papers/29156762PubMed
1734508258The MYC oncogene - the grand orchestrator of cancer growth and immune evasion.Nat Rev Clin Oncol2022https://conductscience.org/library/papers/34508258PubMed
1820513425Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.Mol Cell2010https://conductscience.org/library/papers/20513425PubMed
1934944790Transcriptional Regulation of Amino Acid Transport in Glioblastoma Multiforme.Cancers (Basel)2021https://conductscience.org/library/papers/34944790PubMed
2030071532SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.Cell Physiol Biochem2018https://conductscience.org/library/papers/30071532PubMed

See all 227 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
42457245Serum 1H NMR-Based Untargeted Metabolomics for Noninvasive Early Detection of Breast Cancer.J Proteome Res2026https://conductscience.org/library/papers/42457245PubMed
42123759Plant-Derived Modulators of Tumor Metabolism as Novel, Efficacious, and Low-Toxicity Therapeutic Agents for Cancer Treatment.Molecules2026https://conductscience.org/library/papers/42123759PubMed
42051118Glutamine metabolic enzymes: to filament or not to filament?Biochem Soc Trans2026https://conductscience.org/library/papers/42051118PubMed
41930159Advances in Metabolic Reprogramming and Immune Regulatory Mechanisms in Lung Cancer.Oncol Res2026https://conductscience.org/library/papers/41930159PubMed
41750317Advances in Next-Generation Immunotherapies for Ovarian Cancer: Mechanisms of Immune Evasion and Novel Therapeutic Targets.Biomolecules2026https://conductscience.org/library/papers/41750317PubMed
41744893Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer.Curr Oncol2026https://conductscience.org/library/papers/41744893PubMed
41715146Hydrostatic pressure regulates glutamine metabolism to promote bladder fibroblast activation via the Piezo1/YAP1/GLS1 axis.J Transl Med2026https://conductscience.org/library/papers/41715146PubMed
41624839Immunometabolic editing of the tumor microenvironment: from reprogramming mechanisms to therapeutic vulnerabilities.Front Immunol2025https://conductscience.org/library/papers/41624839PubMed
41584608Pharmacological strategies to overcome immune checkpoint inhibitor resistance in non-small cell lung cancer.Front Oncol2025https://conductscience.org/library/papers/41584608PubMed
41510103Glutamine metabolism drives tumor aggressiveness but not chemoresistance in ovarian carcinoma cell lines.Transl Cancer Res2025https://conductscience.org/library/papers/41510103PubMed
41324718Glutamine reprogramming affects the tumor microenvironment and immune response in hepatocellular carcinoma.Mol Biol Rep2025https://conductscience.org/library/papers/41324718PubMed
41235226Metabolism in the tumor microenvironment: implications for pathogenesis and therapeutics.Front Immunol2025https://conductscience.org/library/papers/41235226PubMed
41050887Novel biomarker identification for oral squamous cell carcinoma development in nonsmoker, nondrinker, and nonchewer patients using third-generation sequencing of oral microbiome.J Oral Microbiol2025https://conductscience.org/library/papers/41050887PubMed
40941035The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/40941035PubMed
40917745Targeting Wnt-driven metabolic adaptations in cancer: integrating glycolysis, glutaminolysis, IDO1-mediated immune evasion, and therapeutic delivery strategies.Front Cell Dev Biol2025https://conductscience.org/library/papers/40917745PubMed
40642957Metabolic hallmarks of trastuzumab resistance.Expert Opin Ther Targets2025https://conductscience.org/library/papers/40642957PubMed
40487432Lifting the veil on tumor metabolism: A GDH1-focused perspective.iScience2025https://conductscience.org/library/papers/40487432PubMed
40483365Elucidating Ras protein as a dual therapeutic target for inflammation and cancer: a review.Discov Oncol2025https://conductscience.org/library/papers/40483365PubMed
40260402Metabolic readouts of tumor instructed normal tissues (TINT) identify aggressive prostate cancer subgroups for tailored therapy.Front Mol Biosci2025https://conductscience.org/library/papers/40260402PubMed
40091629Application of Metabolic Biomarkers in Breast Cancer: A Literature Review.Ann Lab Med2025https://conductscience.org/library/papers/40091629PubMed

See all 30 cited byDownload CSV of cited by

Genes59

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AADAT51166PubTator's text mininghttps://conductscience.org/library/genes/51166NCBI Gene
ATF4468PubTator's text mininghttps://conductscience.org/library/genes/468NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EIF4B1975PubTator's text mininghttps://conductscience.org/library/genes/1975NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
FH2271PubTator's text mininghttps://conductscience.org/library/genes/2271NCBI Gene
GCLC2729PubTator's text mininghttps://conductscience.org/library/genes/2729NCBI Gene
GLS2744PubTator's text mininghttps://conductscience.org/library/genes/2744NCBI Gene
GLS227165PubTator's text mininghttps://conductscience.org/library/genes/27165NCBI Gene
GLUD12746PubTator's text mininghttps://conductscience.org/library/genes/2746NCBI Gene
GLUD22747PubTator's text mininghttps://conductscience.org/library/genes/2747NCBI Gene
GLUL2752PubTator's text mininghttps://conductscience.org/library/genes/2752NCBI Gene
GOT12805PubTator's text mininghttps://conductscience.org/library/genes/2805NCBI Gene
GOT22806PubTator's text mininghttps://conductscience.org/library/genes/2806NCBI Gene
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene

See all 59 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36959802

GET https://conductscience.org/api/papers/v1/36959802/references?page=2